Digest Network Come funziona
Network
/
Società
Co
Non verificato

Convergent Therapeutics Inc.

Di cosa scriviamo

BiotecnologiaFarmaceuticaIndustriaMedicina - VarieSalute

4 comunicati stampa

Guarda tutti i comunicati
29/04/2026
Mercato del lavoro
Scienza
Medicina - Varie
Biotecnologia
Medicina nucleare
Salute
Farmaceutica
Sanità
Oncologia
Convergent Therapeutics Names Andrew Davis Chief Business and Strategy Officer
Fonte
Convergent Therapeutics Inc.
Emittente
Business Wire
1.00
0
21/04/2026
Eventi
Finanza
Industria
Salute
Medicina - Varie
Scienza
Farmaceutica
Biotecnologia
Convergent Therapeutics to Present Phase 2 Data for CONV01-α in Lu-PSMA pretreated Metastatic Castration-Resistant Prostate Cancer Patients at the 2026 ASCO Annual Meeting
Fonte
Convergent Therapeutics Inc.
Emittente
Business Wire
1.00
0
19/03/2026
Convergent Therapeutics Appoints Radiopharmaceutical Industry Veteran Michael Rossi to its Board of Directors
Fonte
Convergent Therapeutics Inc.
Emittente
Business Wire
1.00
0
06/01/2026
Mercato del lavoro
Industria
Oncologia
Salute
Medicina - Varie
Sanità
Farmaceutica
Biotecnologia
Convergent Therapeutics and NorthStar Medical Radioisotopes Announce Expanded Partnership to Support Convergent's Late-Stage Alpha-Emitting Radioantibody Program
Fonte
Convergent Therapeutics Inc.
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0